Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
35.69
+0.09 (0.25%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Neurogene Market Cap
Neurogene has a market cap or net worth of $711.19 million as of August 7, 2026. Its market cap has increased by 134.22% in one year.
Market Cap
711.19M
Enterprise Value
477.14M
1-Year Change
134.22%
Ranking
Category
Stock Price
$35.69
ChartMarket Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $711.19M, an increase of 267.28%. That is a compound annual growth rate of 63.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 711.19M | 122.88% |
| Dec 31, 2025 | 319.09M | -6.03% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
| Dec 19, 2023 | 193.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rigel Pharmaceuticals | 750.37M |
| BridgeBio Oncology Therapeutics | 747.40M |
| Gyre Therapeutics | 743.63M |
| Crescent Biopharma | 720.77M |
| Cybin | 719.64M |
| AgomAb Therapeutics NV | 714.10M |
| Allogene Therapeutics | 693.76M |
| Immix Biopharma | 691.97M |